MedPath

Interstitial Lung Diseases in the Veterans Administration

Conditions
Interstitial Lung Disease
Registration Number
NCT02479126
Lead Sponsor
Robert Tighe
Brief Summary

The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • Interstitial Lung Disease (ILD) ICD-9 code diagnosis 515.0 or 516.3
Exclusion Criteria
  • Inadequate documentation of patient receiving care for ILD in the health records

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Populationup to 5 years
Prevalence of Idiopathic Pulmonary Fibrosis in the VISN6 Veterans Administration Patient Populationup to 5 years
Secondary Outcome Measures
NameTimeMethod
Accuracy of ICD-9 Codes for diagnosis of Interstitial Lung Diseaseup to 5 years

Will compare the reported ICD-9 code diagnosis with the diagnosis made after chart review and re-interpretation of the lung imaging and pathology

Prevalence of Co-morbid Diabetes Mellitus with Interstitial Lung Diseaseup to five years

Compare the prevalence of diabetes with interstitial lung disease as compared to the prevalence of diabetes in the general VA population

Frequency of ICD-9 code diagnosis of Interstitial Lung Disease and clinic consultation with a pulmonary providerup to 5 years

Trial Locations

Locations (1)

Durham VA Medical Center

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath